Creyos

Creyos (formerly Cambridge Brain Sciences) is a leading web-based platform for the assessment of brain health, offering accurate, quantified, and scientifically-validated measures of key aspects of cognition. The company's two core products, Creyos Health and Creyos Research, cater to healthcare practitioners and researchers, respectively. Creyos Health is an online brain health assessment service designed for healthcare practitioners, providing an engaging and enjoyable experience for patients with a reliable and scientifically-validated cognitive assessment report in as little as 15 minutes. It is utilized by leading health care clinics worldwide and offers access to digital versions of standardized patient health questionnaires. On the other hand, Creyos Research is tailored for researchers conducting studies on cognition in academic and commercial settings, enabling the collection of cognitive data at scale and allowing for assessment customization and online administration. The company maintains a global normative database of more than 85,000 participants and has a larger database of 12+ million completed cognitive tasks. Originating from the laboratory of Dr. Adrian Owen, Canada Excellence Research Chair in Cognitive Neuroscience and Imaging, the platform's cognitive tasks have been utilized in over 300 scientific studies, resulting in numerous publications in leading academic journals. Founded in 2014 and headquartered in Canada, Creyos secured a $1.50M debt financing investment from FedDev on 24 July 2023. The company's focus on providing innovative solutions in the healthcare industry and its strong scientific foundations present promising opportunities for further growth and impact in the cognitive health space.